4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001628280-22-005796
Options or other derivatives
- Director acquired 26,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TANNENBAUM RENEE P Director | 2022-03-09 | Grant or award · Stock Options | +26,800 | 70,801 | D | ||
Loading xslF345X03/wf-form4_164695577272689.xml…